Porcine Circovirus Infection is a viral disease of great sanitary and economic importance for the swine industry, primarily associated with Porcine Circovirus type 2 (PCV-2), belonging to the family Circoviridae. It is a widely disseminated disease in swine production systems, related to multifactorial syndromes that compromise the productive performance and health of herds.
Porcine Circovirus is a small, non-enveloped, and highly resistant virus in the environment, which favors its persistence on farms. Transmission occurs horizontally, through direct contact between animals, contaminated secretions, excretions, and fomites, as well as vertically, from the sow to the piglet, contributing to the maintenance of the infection within herds.
Clinically, PCV-2 infection is associated with a set of manifestations known as Porcine Circovirus Associated Diseases (PCVAD). The most common signs include growth retardation, progressive weight loss, lymphadenopathy, respiratory disorders, diarrhea, pallor, and increased mortality, especially in piglets in the nursery and growing phases.
In addition to systemic manifestations, PCV-2 can act as a significant immunosuppressive agent, increasing the susceptibility of animals to secondary bacterial and viral infections. This characteristic reinforces the economic impact of circovirus infection, as it aggravates clinical conditions and raises production costs.
The prevention of Porcine Circovirus Infection is based on a combination of biosecurity measures and efficient vaccination programs. Vaccination against PCV-2 is widely used and considered one of the primary tools for reducing viral load, improving zootechnical performance, and decreasing production losses.
Laboratory diagnosis is fundamental for the confirmation of infection and for monitoring viral circulation in herds. Molecular methods, such as real-time PCR, allow for the detection and quantification of the virus, while histopathological and immunohistochemical examinations assist in the characterization of the associated lesions.
Continuous epidemiological surveillance, associated with proper sanitary management, the control of predisposing factors, and the updating of vaccination programs, is essential for the control of porcine circovirus infection. These actions contribute to the sustainability of production, herd health, and the reduction of the economic impacts of the disease.
In this context, the Bioperfectus Porcine Circovirus (PCV-2) rapid test serves as an effective screening tool to support sanitary surveillance in swine herds. The use of the rapid test enables the agile identification of suspected animals directly in the field, including in the early or subclinical stages of infection, aiding in immediate decision-making such as lot segregation, adjustments in sanitary management, and the evaluation of the efficacy of vaccination programs. In this way, the rapid test complements confirmatory laboratory methods, contributing to the early detection of PCV-2 circulation, the reduction of viral dissemination, and the strengthening of control strategies for porcine circovirus infection.
